Microglia‐specific Alzheimer's disease polygenic risk score predicts longitudinal increase in plasma tau and faster cognitive decline in cognitively unimpaired older adults
Brahyan J. Galindo Mendez, Ling Teng, Gad A. Marshall, Lei Liu, Jasmeer P. Chhatwal, Timothy J. Hohman, Richard P Mayeux, Philip L. De Jager et al.. Alzheimer s & Dementia, 2025-12-01
Topic: Amyloid, tau and blood-test diagnosis
We included 1179 CU subjects (n = 474 females (40%), 70.9 ± 4.5 years old) of European descent who had pTau217 and PACC. Mic-ADPRS was associated with a longitudinal increase in pTau217 (beta = 13.9 x, SE = 2.4 x, p = 0.05). Mic-ADPRS was also associated with faster PACC decline (beta= -15.0 x, SE = 1.8 x, p = < 0.001). Mediation analysis suggests 42% of Mic-ADPRS-PACC association is mediated by increased pTau217. Our findings suggest AD heritability localizing to microglial genes and contribute to increased soluble pTau217 release at a given Aβ burden, which in turn mediates the association between microglial AD genetic risk and cognitive decline. Our results are consistent with previous studies implying microglia in Aβ-related tau accumulation and indicate that much of microglial impact on cognitive decline may occur through accelerated tau pathology in CU older adults.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Mendez, B. J. G., Teng, L., Marshall, G. A., Liu, L., Chhatwal, J. P., Hohman, T. J., et al. (2025). Microglia‐specific Alzheimer's disease polygenic risk score predicts longitudinal increase in plasma tau and faster cognitive decline in cognitively unimpaired older adults. Alzheimer s & Dementia. https://doi.org/10.1002/alz70856_106441
Vancouver
Mendez BJG, Teng L, Marshall GA, Liu L, Chhatwal JP, Hohman TJ, et al. Microglia‐specific Alzheimer's disease polygenic risk score predicts longitudinal increase in plasma tau and faster cognitive decline in cognitively unimpaired older adults. Alzheimer s & Dementia. 2025. doi:10.1002/alz70856_106441. PMID: 41518606.
BibTeX
@article{mendez2025-41518606,
author = {Mendez, Brahyan J. Galindo and Teng, Ling and Marshall, Gad A. and Liu, Lei and Chhatwal, Jasmeer P. and Hohman, Timothy J. and Mayeux, Richard P and De Jager, Philip L. and others},
title = {{Microglia‐specific Alzheimer's disease polygenic risk score predicts longitudinal increase in plasma tau and faster cognitive decline in cognitively unimpaired older adults}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70856_106441},
pmid = {41518606},
url = {https://doi.org/10.1002/alz70856_106441}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- We included 1179 CU subjects (n = 474 females (40%), 70.9 ± 4.5 years old) of European descent who had pTau217 and PACC.
- Mic-ADPRS was associated with a longitudinal increase in pTau217 (beta = 13.9 x, SE = 2.4 x, p = 0.05).
- Mic-ADPRS was also associated with faster PACC decline (beta= -15.0 x, SE = 1.8 x, p = < 0.001).
- Mediation analysis suggests 42% of Mic-ADPRS-PACC association is mediated by increased pTau217.
- Our findings suggest AD heritability localizing to microglial genes and contribute to increased soluble pTau217 release at a given Aβ burden, which in turn mediates the association between microglial AD genetic risk and cognitive decline.
Why it matters
In cognitively unimpaired older adults, a microglia-specific Alzheimer polygenic risk score predicted a longitudinal increase in plasma tau and faster cognitive decline. The findings suggest that much of the microglial effect on cognitive decline may occur through accelerated tau pathology, but no treatment is tested.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designlongitudinal study
- Participants474
- Evidence strengthModerate
How this study scored 49/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 474 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Hyun‐Sik Yang: h-index 34 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multi-centre collaboration | 2 / 3 | OpenAlex lists 9 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41518606) |
| Free to read | 2 / 2 | Free to read |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70856_106441
- PubMed: 41518606
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related studies in Genetics
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.